Skip to main content
. 2018 Oct 29;54(1):128–138. doi: 10.3892/ijo.2018.4610

Figure 1.

Figure 1

miR-98-5p is downregulated in human NSCLC tissues and is associated with progression. (A) The expression levels of miR-98-5p in 70 paired NSCLC tissues and adjacent normal tissues. (B) The expression levels of miR-98-5p were downregulated in NSCLC tissues in comparison with adjacent normal tissues. (C) The expression levels of miR-98-5p in different clinical stages (I and III) in NSCLC. (D) The expression levels of miR-98-5p in metastatic and non-metastatic NSCLC. NSCLC, non-small cell lung cancer. *P<0.05.